Echo Therapeutics (ECTE) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS
Echo Therapeutics (NASDAQ:ECTE) released its earnings data on Thursday. The company reported ($0.31) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.23) by $0.08, AnalystRatingsNetwork reports. The company had revenue of $19.10 million for the quarter, compared to the consensus estimate of $22.56 million.
Shares of Echo Therapeutics (NASDAQ:ECTE) traded up 5.14% during mid-day trading on Thursday, hitting $1.84. 28,963 shares of the company’s stock traded hands. Echo Therapeutics has a 52-week low of $1.53 and a 52-week high of $4.91. The stock has a 50-day moving average of $2.0 and a 200-day moving average of $2.60. The company’s market cap is $22.0 million.
Echo Therapeutics, Inc (NASDAQ:ECTE) is a medical device and specialty pharmaceutical company.
Receive News & Ratings for Echo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Echo Therapeutics and related companies with Analyst Ratings Network's FREE daily email newsletter.